Correspondence to: Woo-Chul Chung this site.

Correspondence to: Woo-Chul Chung, Department of Internal Medicine, Vincent Hospital, The Catholic University, 93 Ji-dong, Paldal-gu, Suwon-si, Gyunggi-do 442-723,About World Journal of GastroenterologyWorld Journal of Gastroenterology , a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, hepatitis, colorectal cancer, and H pylori infection for providing a forum for clinicians and scientists this site . WJG has been indexed and abstracted in Current Contents / Clinical Medicine, Science Citation Index Expanded and Journal Citation Reports / Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE / Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2003-2000 IF: 3.445, and 0, a weekly magazine published by WJG Press WJG is published. The dates are the 7th Day of each month. The WJG the National Natural Science the National Natural Science Foundation of China, No. 30224801 and 30424812, and was on the name of China National Journal of New Gastroenterology 1st Founded in October 1995 , and renamed WJG on 25 January 1998.

This case report a team led by a team led by Dr. Chung Woo-Chul from the Catholic University of Korea , 14 April 2008 in the World Journal of Gastroenterology published.

Volunteers vaccine shows pledge in preventing cytomegalovirus infection.

Doctors from prescribing warfarin for treatment or prevention of blood clots. But an overdosage with warfarin blood can about much thinner, making one bleeding Banquet. Of vitamin K rapidly of of an warfarin Overdosage. However there were not known, such as vitamin K affects treatment results. Researchers sought to determine if the patient intake of vitamin K. Has less bleeding or greater risk of blood clots. They carried out a study of 712 people taking warfarin of which the blood demonstrated her blood too thin. The patient stops taking warfarin and randomly either low dose of vitamin K or placebo over a 90-day period of time. The investigators found that vitamin K reduced rapidly the impact of warfarin. However, there were no difference between the groups to the number of participants to bleeding, clots or other complications. Researchers believe that warfarin can temporarily stopping media what is needed to reduce the impact of too many warfarin be treated.